Flora Growth (FLGC) Stock Price, News & Analysis

Company Overview

Flora Growth is a diversified agriculture and cannabis company focused on the research, development and commercialization of cannabinoid-based products. Operating under a fully integrated business model, the company cultivates proprietary strains, extracts active compounds and manufactures finished goods for both medical and wellness markets. By leveraging advanced agritech practices and proprietary extraction methods, Flora Growth aims to optimize yield, safety and consistency across its product lines.

The company’s portfolio encompasses a broad range of offerings, including tinctures, topical creams, soft gels and pure cannabidiol (CBD) powders. In addition to its consumer brands, Flora Growth provides white-label and private-label manufacturing services for third-party partners. Its in-house research and development teams focus on formulation science, process optimization and the exploration of lesser-known cannabinoids, positioning Flora Growth at the forefront of product innovation in the evolving cannabis space.

Flora Growth serves markets across North and Latin America, with cultivation facilities in Colombia and Canada. The company also operates e-commerce platforms targeting key markets in the United States and Europe. By combining its international cultivation infrastructure with global distribution channels, Flora Growth seeks to address varying regulatory frameworks and consumer preferences while ensuring product accessibility and regulatory compliance in each jurisdiction.

Founded by a team of agricultural scientists and industry veterans, Flora Growth is led by CEO Hans Hillebrand, whose background spans biotechnology, pharmaceuticals and supply-chain management. Under his leadership, the company has expanded its footprint through strategic partnerships and investments in research collaborations. Flora Growth’s management emphasizes transparency, quality control and sustainable cultivation practices as pillars of its long-term growth strategy in the competitive cannabinoid market.

Key Stats

• Today's Range: $0.66 to $0.70
• 50-Day Range: $0.56 to $0.78
• 52-Week Range: $0.42 to $2.11
• Volume: 47,745 shs
• Average Volume: 273,218 shs
• Market Capitalization: $15.08 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.00
• Consensus Rating: Moderate Buy

Flora Growth Stock Analysis - MarketRank™

Flora Growth scored higher than 50% of companies evaluated by MarketBeat, and ranked 581st out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Flora Growth has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Flora Growth has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Flora Growth are expected to grow in the coming year, from ($0.93) to ($0.18) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Flora Growth is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Flora Growth is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Flora Growth has a P/B Ratio of 2.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.57% of the float of Flora Growth has been sold short.

Short Interest Ratio / Days to Cover

Flora Growth has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Flora Growth has recently increased by 75.74%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Flora Growth does not currently pay a dividend.

Dividend Growth

Flora Growth does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.57% of the float of Flora Growth has been sold short.

Short Interest Ratio / Days to Cover

Flora Growth has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Flora Growth has recently increased by 75.74%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: N/A

News Sentiment

Flora Growth has a news sentiment score of 1.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Flora Growth this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Flora Growth insiders have not sold or bought any company stock.

Percentage Held by Insiders

12.56% of the stock of Flora Growth is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 36.01% of the stock of Flora Growth is held by institutions.

FLGC Stock Analysis - Frequently Asked Questions

How have FLGC shares performed this year?

Flora Growth's stock was trading at $1.03 at the beginning of the year. Since then, FLGC shares have decreased by 33.1% and is now trading at $0.6890.

How were Flora Growth's earnings last quarter?

Flora Growth Corp. (NASDAQ:FLGC) released its earnings results on Tuesday, May, 13th. The company reported ($0.04) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.03. The business earned $11.79 million during the quarter, compared to the consensus estimate of $14.79 million. Flora Growth had a negative net margin of 24.85% and a negative trailing twelve-month return on equity of 216.49%.

When did Flora Growth's stock split?

Flora Growth shares reverse split on Friday, June 9th 2023.The 1-20 reverse split was announced on Friday, June 9th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 9th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Flora Growth IPO?

Flora Growth (FLGC) raised $15 million in an initial public offering (IPO) on Tuesday, May 11th 2021. The company issued 3,300,000 shares at $4.00-$5.00 per share. Boustead Securities served as the underwriter for the IPO.

How do I buy shares of Flora Growth?

Shares of FLGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Flora Growth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Flora Growth investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Pfizer (PFE), Tesla (TSLA), NIO (NIO) and

Company Calendar

• Last Earnings: 5/13/2025
• Today: 7/15/2025
• Next Earnings (Estimated): 8/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:FLGC
• CIK: 1790169
• Web: floragrowth.ca
• Phone: 954-842-4989
• Fax: N/A
• Employees: 280
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Flora Growth: $4.00
• High Price Target: $4.00
• Low Price Target: $4.00
• Potential Upside/Downside: +480.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.98)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$15.91 million
• Net Margins: -24.85%
• Pretax Margin: -25.46%
• Return on Equity: -216.49%
• Return on Assets: -45.56%

Debt

• Debt-to-Equity Ratio: 0.88
• Current Ratio: 1.05
• Quick Ratio: 0.67

Sales & Book Value

• Annual Sales: $53.26 million
• Price / Sales: 0.29
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.31 per share
• Price / Book: 2.22

Miscellaneous

• Outstanding Shares: 22,569,000
• Free Float: 19,734,000
• Market Cap: $15.55 million
• Optionable: Not Optionable
• Beta: 1.97